Siemens Aktiengesellschaft (SIEGY) Analysts See $0.97 EPS; S&T Bank Has Cut By $385,730 Its Myriad Genetics (MYGN) Stake

April 14, 2018 - By Ruchi Gupta

Siemens Aktiengesellschaft (OTCMKTS:SIEGY) Logo

Analysts expect Siemens Aktiengesellschaft (OTCMKTS:SIEGY) to report $0.97 EPS on May, 3.They anticipate $0.06 EPS change or 6.59% from last quarter’s $0.91 EPS. SIEGY’s profit would be $1.60 billion giving it 16.66 P/E if the $0.97 EPS is correct. After having $1.54 EPS previously, Siemens Aktiengesellschaft’s analysts see -37.01% EPS growth. The stock decreased 0.02% or $0.015 during the last trading session, reaching $64.645. About 110,605 shares traded. Siemens Aktiengesellschaft (OTCMKTS:SIEGY) has 0.00% since April 14, 2017 and is . It has underperformed by 11.55% the S&P500.

S&T Bank decreased Myriad Genetics Inc (MYGN) stake by 2.33% reported in 2017Q4 SEC filing. S&T Bank sold 11,345 shares as Myriad Genetics Inc (MYGN)’s stock declined 14.14%. The S&T Bank holds 476,156 shares with $16.35M value, down from 487,501 last quarter. Myriad Genetics Inc now has $2.03B valuation. The stock increased 0.14% or $0.04 during the last trading session, reaching $29.09. About 288,533 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has risen 52.68% since April 14, 2017 and is uptrending. It has outperformed by 41.13% the S&P500.

Investors sentiment increased to 1.37 in 2017 Q4. Its up 0.51, from 0.86 in 2017Q3. It is positive, as 19 investors sold MYGN shares while 67 reduced holdings. 46 funds opened positions while 72 raised stakes. 71.43 million shares or 0.51% less from 71.79 million shares in 2017Q3 were reported. Camber Cap Llc, a Massachusetts-based fund reported 1.50 million shares. Robeco Institutional Asset Mgmt Bv owns 174,098 shares. Caisse De Depot Et Placement Du Quebec has invested 0.04% in Myriad Genetics, Inc. (NASDAQ:MYGN). Convergence Invest Prtnrs Ltd Llc reported 0.51% stake. Hanseatic Mngmt Service Inc holds 0% or 72 shares. Piedmont Investment Advsrs Ltd holds 0.05% or 68,236 shares. State Of Wisconsin Board accumulated 63,800 shares. Texas Permanent School Fund invested in 46,804 shares or 0.02% of the stock. Teachers Retirement Systems Of The State Of Kentucky, a Kentucky-based fund reported 23,600 shares. Citigroup stated it has 0% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN). The Illinois-based Balyasny Asset Mngmt Limited Liability has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Northwestern Mutual Wealth Mngmt Comm has invested 0% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN). Moreover, Smithfield Trust Com has 0% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 65 shares. Cwm holds 0.46% or 302,093 shares in its portfolio. Jpmorgan Chase And accumulated 279,857 shares.

Among 20 analysts covering Myriad Genetics (NASDAQ:MYGN), 4 have Buy rating, 4 Sell and 12 Hold. Therefore 20% are positive. Myriad Genetics had 59 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Mizuho with “Neutral” on Tuesday, September 15. As per Tuesday, January 2, the company rating was maintained by Stephens. As per Tuesday, August 8, the company rating was maintained by Piper Jaffray. The rating was downgraded by Gabelli on Wednesday, August 10 to “Hold”. The company was upgraded on Friday, August 18 by Deutsche Bank. The stock has “Buy” rating by Gabelli on Tuesday, July 21. The firm earned “Hold” rating on Thursday, August 11 by Jefferies. Cowen & Co maintained Myriad Genetics, Inc. (NASDAQ:MYGN) on Friday, September 15 with “Hold” rating. The company was downgraded on Wednesday, November 2 by Stephens. The rating was maintained by Mizuho with “Neutral” on Wednesday, November 4.

Analysts await Myriad Genetics, Inc. (NASDAQ:MYGN) to report earnings on May, 1. They expect $0.27 earnings per share, 0.00% or $0.00 from last year’s $0.27 per share. MYGN’s profit will be $18.86M for 26.94 P/E if the $0.27 EPS becomes a reality. After $0.31 actual earnings per share reported by Myriad Genetics, Inc. for the previous quarter, Wall Street now forecasts -12.90% negative EPS growth.

Since December 11, 2017, it had 0 insider buys, and 7 sales for $5.48 million activity. On Thursday, January 18 the insider MARSH RICHARD M sold $1.53 million. GILBERT WALTER PHD had sold 7,500 shares worth $248,925. King Gary A. also sold $1.37M worth of Myriad Genetics, Inc. (NASDAQ:MYGN) on Monday, January 22. $201,000 worth of Myriad Genetics, Inc. (NASDAQ:MYGN) was sold by DREISMANN HEINRICH on Monday, December 11.

Myriad Genetics, Inc. (NASDAQ:MYGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News